Skip to main content
logo
Cytogen, Inc. (KOSDAQ:217330)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,675.00
+5.00 (0.14%)
At close: Aug 11, 2026

Cytogen Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
26,83726,05510,9113,184760.78347.85
Revenue Growth
70.81%138.80%242.63%318.57%118.71%-
Gross Profit
6,1155,6152,829846.22195.1957.28
Operating Income
-7,267-8,163-10,666-11,792-11,497-12,861
Net Income
-11,184-12,343-17,117-15,770-18,771-10,871
Earnings Per Share
-484.93-535.03-758.00-862.29-1063.00-642.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
25,00631,51341,26654,88717,92235,803
Total Debt
15,40816,27914,87217,57626,42424,624
Net Cash (Debt)
9,59815,23326,39537,311-8,50211,179
Net Cash Growth
-59.29%-42.29%-29.26%---
Net Cash Per Share
416.14660.311168.852040.21-481.37659.73

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7,681-6,954-9,529-7,594-6,379-5,230
Capital Expenditures
-1,925-1,970-1,007-2,498-645.8-1,219
Free Cash Flow
-9,606-8,924-10,536-10,092-7,024-6,449
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
22.79%21.55%25.93%26.57%25.66%16.47%
Operating Margin
-27.08%-31.33%-97.75%-370.30%-1511.28%-3697.31%
Pretax Margin
-44.38%-49.71%-164.35%-508.09%-2456.92%-3830.07%
Profit Margin
-41.68%-47.37%-156.88%-495.22%-2467.37%-3125.13%
FCF Margin
-35.80%-34.25%-96.56%-316.91%-923.33%-1853.87%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
3.167.969.5980.79380.491022.63